Bayesian Capital Management’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-520
Closed -$216K – 333
2026
Q2
$216K Buy
+520
New +$193K 0.14% 193
2025
Q4
– Sell
-13,900
Closed -$4.8M – 529
2025
Q3
$4.8M Buy
+13,900
New +$4.2M 0.98% 8
2025
Q2
– Sell
-700
Closed -$367K – 886
2025
Q1
$367K Sell
700
-5,007
-88% -$2.56M 0.06% 348
2024
Q4
$2.89M Buy
+5,707
New +$3.24M 0.35% 78
2024
Q3
– Sell
-12,300
Closed -$6.26M – 1052
2024
Q2
$6.26M Buy
+12,300
New +$6.03M 0.72% 18
2024
Q1
– Sell
-3,600
Closed -$1.9M – 1137
2023
Q4
$1.9M Sell
3,600
-7,100
-66% -$3.79M 0.2% 136
2023
Q3
$5.39M Buy
10,700
+1,150
+12% +$566K 0.62% 30
2023
Q2
$4.59M Buy
9,550
+5,450
+133% +$2.66M 0.49% 33
2023
Q1
$1.94M Buy
+4,100
New +$1.98M 0.24% 114
2022
Q3
– Sell
-2,600
Closed -$1.34M – 1029
2022
Q2
$1.34M Buy
+2,600
New +$1.31M 0.25% 106
2021
Q4
– Sell
-1,654
Closed -$646K – 522
2021
Q3
$646K Buy
+1,654
New +$685K 0.19% 146
2020
Q4
– Sell
-9,441
Closed -$2.94M – 671
2020
Q3
$2.94M Buy
9,441
+8,229
+679% +$2.53M 0.72% 20
2020
Q2
$357K Sell
1,212
-3,188
-72% -$913K 0.08% 314
2020
Q1
$1.1M Buy
+4,400
New +$1.21M 0.24% 107
2019
Q4
– Sell
-43,076
Closed -$9.36M – 761
2019
Q3
$9.36M Buy
43,076
+36,623
+568% +$8.84M 1.77% 5
2019
Q2
$1.58M Sell
6,453
-8,876
-58% -$2.13M 0.33% 86
2019
Q1
$3.79M Buy
15,329
+12,500
+442% +$3.19M 0.73% 20
2018
Q4
$705K Buy
+2,829
New +$747K 0.14% 213
2018
Q3
– Sell
-7,705
Closed -$1.89M – 801
2018
Q2
$1.89M Buy
7,705
+5,905
+328% +$1.42M 0.43% 54
2018
Q1
$385K Sell
1,800
-10,900
-86% -$2.49M 0.1% 333
2017
Q4
$2.8M Buy
+12,700
New +$2.69M 0.57% 23
2017
Q1
– Sell
-13,261
Closed -$2.12M – 699
2016
Q4
$2.12M Buy
+13,261
New +$1.98M 0.53% 11

Other funds holding UNH

Bayesian Capital Management's UNH Position: Q3 2026 in Review

Bayesian Capital Management sold out of UnitedHealth (UNH) in Q3 2026, closing a stake of 520 shares — an estimated $216K sold.

Bayesian Capital Management first reported a position in UNH in Q4 2016 and held it in 22 quarters. The position peaked at $9.36M in Q3 2019. 3,293 funds tracked by Wall St. Rank hold UNH as of Q3 2026.

  • Bayesian Capital Management reported no remaining UnitedHealth position as of Q3 2026 after selling out during the quarter.
  • Bayesian Capital Management sold 520 UnitedHealth shares in Q3 2026, an estimated $216K.
  • Bayesian Capital Management first reported a position in UnitedHealth in Q4 2016 and held it in 22 quarters.
  • Bayesian Capital Management's UnitedHealth position peaked at $9.36M in Q3 2019.
  • 3,293 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2026.

Based on Bayesian Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.